Huang Wenfei, Penaherrera Erika P, Desir Danaika F, Gamarro Dominick L, Cottrell Jessica, Chu Tinchun, Chang Sulie L
Department of Biological Sciences, Seton Hall University, South Orange, NJ, USA.
Institute of NeuroImmune Pharmacology, Seton Hall University, South Orange, NJ, USA.
J Drug Alcohol Res. 2019 Oct 18;2019.
Alcohol is the most widely used addictive substance. Severe alcohol abuse is diagnosed as "alcohol use disorder" (AUD). A common and harmful drinking pattern is binge drinking that elevates a person's blood alcohol concentration to ≥ 0.08%. Such drinking may be an early indicator of AUD. Opioid misuse and dependence have become worldwide crises. Patterned consumption of various opioids can develop into opioid use disorder (OUD). An intertwined epidemic exists between opioid abuse, alcohol addiction, and binge drinking. Currently, studies on the interaction of AUD and OUD are limited and the underlying mechanisms linking these disorders remains unclear. We reviewed studies on AUD and OUD and utilized Ingenuity Pathway Analysis (IPA) to identify mechanisms of AUD and OUD interaction and potential gene targets for therapeutic agents. According to IPA Canonical Pathways Analysis, Gamma-aminobutyric Acid (GABA) Receptor Signaling, Neuroinflammation Signaling Pathway, Opioid Signaling Pathway and Dopamine-DARPP32 Feedback in cAMP Signaling are potential contributors to the interaction of AUD and OUD.
酒精是使用最为广泛的成瘾性物质。严重酒精滥用被诊断为“酒精使用障碍”(AUD)。一种常见且有害的饮酒模式是狂饮,它会使一个人的血液酒精浓度升高至≥0.08%。这种饮酒行为可能是酒精使用障碍的早期指标。阿片类药物的滥用和依赖已成为全球性危机。各种阿片类药物的模式化使用会发展为阿片类药物使用障碍(OUD)。阿片类药物滥用、酒精成瘾和狂饮之间存在相互交织的流行情况。目前,关于酒精使用障碍和阿片类药物使用障碍相互作用的研究有限,且将这些障碍联系起来的潜在机制仍不清楚。我们回顾了关于酒精使用障碍和阿片类药物使用障碍的研究,并利用 Ingenuity 通路分析(IPA)来确定酒精使用障碍和阿片类药物使用障碍相互作用的机制以及治疗药物的潜在基因靶点。根据 IPA 经典通路分析,γ-氨基丁酸(GABA)受体信号传导、神经炎症信号通路、阿片类药物信号通路以及 cAMP 信号传导中的多巴胺-DARPP32 反馈是酒精使用障碍和阿片类药物使用障碍相互作用的潜在因素。